← Back to Screener
Jyong Biotech Ltd. Ordinary Shares (MENS)
Price$2.31
Favorite Metrics
Price vs S&P 500 (26W)-104.33%
Price vs S&P 500 (4W)34.04%
Market Capitalization$185.51M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-42.37%
EPS (TTM)$-0.06
10-Day Avg Trading Volume0.12M
EPS Excl Extra (TTM)$-0.06
EPS (Annual)$-0.04
Cash / Share (Quarterly)$0.23
ROA (Last FY)-47.42%
EBITD / Share (TTM)$-0.04
Cash Flow / Share (Annual)$-0.05
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-1.94x
ROA (TTM)-19.40%
EPS Incl Extra (Annual)$-0.04
Current Ratio (Annual)0.02x
Quick Ratio (Quarterly)0.62x
3-Month Avg Trading Volume0.70M
Revenue / Employee (TTM)$0
52-Week High$67.00
EPS Excl Extra (Annual)$-0.04
26-Week Price Return-95.58%
Quick Ratio (Annual)0.01x
13-Week Price Return-28.86%
Current Ratio (Quarterly)0.62x
Enterprise Value$220.432
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.00
3-Month Return Std Dev134.17%
Net Income / Employee (TTM)$-0
Net Interest Coverage (Annual)-2.01x
EPS Basic Excl Extra (Annual)$-0.04
EPS Incl Extra (TTM)$-0.06
Revenue / Share (Annual)$0.00
Year-to-Date Return-38.23%
5-Day Price Return-12.54%
EPS Normalized (Annual)$-0.04
Month-to-Date Return13.49%
EBITD / Share (Annual)$-0.02
EPS Basic Excl Extra (TTM)$-0.06
Price vs S&P 500 (13W)-31.73%
Beta3.33x
Revenue / Share (TTM)$0.00
52-Week Low$1.43
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
MENSJyong Biotech Ltd. Ordinary Shares | — | — | — | — | $2.31 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Jyong Biotech is a Taiwan-based biotechnology company focused on developing plant-derived therapeutics for urinary system diseases. Its pipeline includes a lead candidate in NDA submission, a clinical-stage program, and preclinical assets, targeting the U.S., European, and Asian markets.